Loan Election Agreement Between the California Institute for Regenerative Medicine and Capricor, Inc.Agreement • August 15th, 2016 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
This agreement (the “Agreement”) between the California Institute for Regenerative Medicine (“CIRM”) and Capricor, Inc. (“Capricor”) is entered into and is effective as of June 20, 2016, and sets forth the terms pursuant to which Capricor and CIRM agree to negotiate a loan agreement should Capricor elect to treat its award (CLIN2-08334) (the “Award”) as a loan pursuant to CIRM’s loan election policy (Clinical Grants Administration Policy, art. IV (c)) (the “Loan Policy”).
THIRD AMENDMENT TO LEASELease • August 15th, 2016 • Capricor Therapeutics, Inc. • Pharmaceutical preparations
This Third Amendment to Lease (this “Amendment”) is dated as of May 25, 2016, and is made by and between The Bubble Real Estate Company, LLC, a California limited liability company (“Lessor”) and Capricor, Inc., a Delaware corporation (“Lessee”), with reference to the following facts and circumstances:
